Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Interactions between pain states and opioid reward assessed with intracranial self-stimulation in rats.

Moerke MJ, Negus SS.

Neuropharmacology. 2019 Dec 1;160:107689. doi: 10.1016/j.neuropharm.2019.107689. Epub 2019 Jul 1. Review.

PMID:
31271771
2.

Role of agonist efficacy in exposure-induced enhancement of mu opioid reward in rats.

Moerke MJ, Negus SS.

Neuropharmacology. 2019 Jun;151:180-188. doi: 10.1016/j.neuropharm.2019.03.020. Epub 2019 Mar 14.

PMID:
30880123
3.

Discriminative stimulus effects of mecamylamine and nicotine in rhesus monkeys: Central and peripheral mechanisms.

Cunningham CS, Moerke MJ, McMahon LR.

Pharmacol Biochem Behav. 2019 Apr;179:27-33. doi: 10.1016/j.pbb.2019.02.002. Epub 2019 Feb 6.

PMID:
30738085
4.

Nicotine-like discriminative stimulus effects of acetylcholinesterase inhibitors and a muscarinic receptor agonist in Rhesus monkeys.

Moerke MJ, McMahon LR.

Drug Dev Ind Pharm. 2019 May;45(5):861-867. doi: 10.1080/03639045.2019.1578787. Epub 2019 Feb 22.

PMID:
30712397
5.

Effects of the α2/α3-subtype-selective GABAA receptor positive allosteric modulator KRM-II-81 on pain-depressed behavior in rats: comparison with ketorolac and diazepam.

Moerke MJ, Li G, Golani LK, Cook J, Negus SS.

Behav Pharmacol. 2019 Aug;30(5):452-461. doi: 10.1097/FBP.0000000000000464.

PMID:
30640180
6.

Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.

Sakloth F, Leggett E, Moerke MJ, Townsend EA, Banks ML, Negus SS.

Exp Clin Psychopharmacol. 2019 Jun;27(3):215-226. doi: 10.1037/pha0000253. Epub 2019 Jan 10.

PMID:
30628811
7.

Determinants of opioid abuse potential: Insights using intracranial self-stimulation.

Negus SS, Moerke MJ.

Peptides. 2019 Feb;112:23-31. doi: 10.1016/j.peptides.2018.10.007. Epub 2018 Nov 1. Review.

PMID:
30391425
8.

Interactions between Cocaine and the Putative Allosteric Dopamine Transporter Ligand SRI-31142.

Moerke MJ, Ananthan S, Banks ML, Eltit JM, Freitas KC, Johnson AR, Saini SK, Steele TWE, Negus SS.

J Pharmacol Exp Ther. 2018 Nov;367(2):222-233. doi: 10.1124/jpet.118.250902. Epub 2018 Aug 27.

9.

Rapid nicotine tolerance and cross-tolerance to varenicline in rhesus monkeys: Drug discrimination.

Moerke MJ, McMahon LR.

Exp Clin Psychopharmacol. 2018 Dec;26(6):541-548. doi: 10.1037/pha0000226. Epub 2018 Aug 13.

PMID:
30102063
10.

Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats.

Lazenka ML, Moerke MJ, Townsend EA, Freeman KB, Carroll FI, Negus SS.

Psychopharmacology (Berl). 2018 Jan;235(1):203-213. doi: 10.1007/s00213-017-4758-7. Epub 2017 Oct 24.

11.

Maintenance on naltrexone+amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys.

Moerke MJ, Banks ML, Cheng K, Rice KC, Negus SS.

Drug Alcohol Depend. 2017 Dec 1;181:85-93. doi: 10.1016/j.drugalcdep.2017.09.020. Epub 2017 Oct 13.

12.

The discriminative stimulus effects of i.v. nicotine in rhesus monkeys: Pharmacokinetics and apparent pA2 analysis with dihydro-β-erythroidine.

Moerke MJ, Zhu AZ, Tyndale RF, Javors MA, McMahon LR.

Neuropharmacology. 2017 Apr;116:9-17. doi: 10.1016/j.neuropharm.2016.12.003. Epub 2016 Dec 8.

13.

Attenuated nicotine-like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine daily.

Cunningham CS, Moerke MJ, Javors MA, Carroll FI, McMahon LR.

Br J Pharmacol. 2016 Dec;173(24):3454-3466. doi: 10.1111/bph.13635. Epub 2016 Nov 6.

14.

Effects of nicotine in combination with drugs described as positive allosteric nicotinic acetylcholine receptor modulators in vitro: discriminative stimulus and hypothermic effects in mice.

Moerke MJ, de Moura FB, Koek W, McMahon LR.

Eur J Pharmacol. 2016 Sep 5;786:169-178. doi: 10.1016/j.ejphar.2016.05.032. Epub 2016 May 27.

15.

The discriminative stimulus effects of mecamylamine in nicotine-treated and untreated rhesus monkeys.

Cunningham CS, Moerke MJ, McMahon LR.

Behav Pharmacol. 2014 Aug;25(4):296-305. doi: 10.1097/FBP.0000000000000054.

Supplemental Content

Loading ...
Support Center